These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 14594906)

  • 21. [Antipsychotic drugs and cardiovascular safety: need for monitoring the QT interval].
    Trojak B; Pinoit JM; André D; Bonin B; Gisselmann A
    Presse Med; 2006 Apr; 35(4 Pt 2):699-704. PubMed ID: 16614617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone.
    Atar S; Freedberg NA; Antonelli D; Rosenfeld T
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):785-6. PubMed ID: 12698686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Torsades de pointes induced by nonantiarrhythmic drugs.
    Tran HT
    Conn Med; 1994 May; 58(5):291-5. PubMed ID: 7915666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QTc prolongation and haloperidol: just how risky is this drug?
    Howland RH
    Psychosomatics; 2014; 55(6):741-2. PubMed ID: 25497511
    [No Abstract]   [Full Text] [Related]  

  • 26. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What has the patient been taking?
    Pasco J
    Aust Fam Physician; 1998 Jun; 27(6):517. PubMed ID: 9648320
    [No Abstract]   [Full Text] [Related]  

  • 28. [QTc-prolonging drugs and the risk of sudden death].
    Reingardiene D; Vilcinskaite J
    Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk management of QT-prolonging drugs by community pharmacists using a mobile electrocardiograph].
    Shinozaki K
    Yakugaku Zasshi; 2010 Nov; 130(11):1597-601. PubMed ID: 21048421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline.
    Dorsey ST; Biblo LA
    Am J Emerg Med; 2000 Mar; 18(2):227-9. PubMed ID: 10750939
    [No Abstract]   [Full Text] [Related]  

  • 31. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
    Zeltser D; Justo D; Halkin A; Prokhorov V; Heller K; Viskin S
    Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
    Letsas KP; Filippatos GS; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Cardiology; 2006; 105(3):146-7. PubMed ID: 16449812
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding drug-induced torsades de pointes: a genetic stance.
    Kannankeril PJ
    Expert Opin Drug Saf; 2008 May; 7(3):231-9. PubMed ID: 18462182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide.
    Asajima H; Saito N; Ohmura Y; Ohmura K
    Eur J Clin Pharmacol; 2012 Mar; 68(3):331-3. PubMed ID: 21898101
    [No Abstract]   [Full Text] [Related]  

  • 35. Drugs, QT interval abnormalities and ventricular arrhythmias.
    Thomas SH
    Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900
    [No Abstract]   [Full Text] [Related]  

  • 36. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
    Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
    Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probable Acquired QTc Prolongation and Subsequent Torsades de Pointes Attributable to Quetiapine.
    Giancaterino S; Solimine S
    Prim Care Companion CNS Disord; 2017 Nov; 19(6):. PubMed ID: 29190419
    [No Abstract]   [Full Text] [Related]  

  • 39. Doxepin-induced torsade de pointes tachycardia.
    Alter P; Tontsch D; Grimm W
    Ann Intern Med; 2001 Sep; 135(5):384-5. PubMed ID: 11529713
    [No Abstract]   [Full Text] [Related]  

  • 40. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D
    Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.